Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase. | Sci Rep | 2023 | 37280236 | PubTator, text mining | PubMed |
| Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models. | Transl Oncol | 2023 | 37271121 | PubTator, text mining | PubMed |
| A resource of human coronavirus protein-coding sequences in a flexible, multipurpose Gateway Entry clone collection. | G3 (Bethesda) | 2023 | 37267226 | PubTator, text mining | PubMed |
| In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors. | 3 Biotech | 2023 | 37265541 | PubTator, text mining | PubMed |
| Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19. | Pharmaceuticals (Basel) | 2023 | 37259339 | PubTator, text mining | PubMed |
| Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks. | Front Microbiol | 2023 | 37250046 | PubTator, text mining | PubMed |
| The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022. | Eur J Med Chem | 2023 | 37244162 | PubTator, text mining | PubMed |
| The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. | Viruses | 2023 | 37243158 | PubTator, text mining | PubMed |
| Allicin Inhibits Porcine Reproductive and Respiratory Syndrome Virus Infection In Vitro and Alleviates Inflammatory Responses. | Viruses | 2023 | 37243135 | PubTator, text mining | PubMed |
| A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide. | Pharmaceuticals (Basel) | 2023 | 37242424 | PubTator, text mining | PubMed |
| Antiviral Therapy of COVID-19. | Int J Mol Sci | 2023 | 37240213 | PubTator, text mining | PubMed |
| Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease. | Int J Mol Sci | 2023 | 37239980 | PubTator, text mining | PubMed |
| Novel Differentially Methylated Regions Identified by Genome-Wide DNA Methylation Analyses Contribute to Racial Disparities in Childhood Obesity. | Genes (Basel) | 2023 | 37239458 | PubTator, text mining | PubMed |
| Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease. | Biomolecules | 2023 | 37238714 | PubTator, text mining | PubMed |
| Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment. | Signal Transduct Target Ther | 2023 | 37217487 | PubTator, text mining | PubMed |
| Natural flavonols: actions, mechanisms, and potential therapeutic utility for various diseases. | Beni Suef Univ J Basic Appl Sci | 2023 | 37216013 | PubTator, text mining | PubMed |
| Characters of KRT80 and its roles in neoplasms diseases. | Cancer Med | 2023 | 37211956 | PubTator, text mining | PubMed |
| Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains. | J Virol | 2023 | 37199624 | PubTator, text mining | PubMed |
| Integrative Approach to Dissect the Drug Resistance Mechanism of the H172Y Mutation of SARS-CoV-2 Main Protease. | J Chem Inf Model | 2023 | 37199464 | PubTator, text mining | PubMed |
| Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2. | MedComm (2020) | 2023 | 37193304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=14